Aloxiprin
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| |
| Aloxiprin
| |
| Systematic (IUPAC) name | |
| aluminum 2-acetyloxybenzoate hydroxide | |
| Identifiers | |
| CAS number | |
| ATC code | B01 |
| PubChem | |
| Chemical data | |
| Formula | C18H15O9 |
| Mol. mass | 402.288 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Aloxiprin | |
|
Articles | |
|---|---|
|
Most recent articles on Aloxiprin | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Aloxiprin at Clinical Trials.gov Clinical Trials on Aloxiprin at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Aloxiprin
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Aloxiprin Discussion groups on Aloxiprin Directions to Hospitals Treating Aloxiprin Risk calculators and risk factors for Aloxiprin
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Aloxiprin | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Aloxiprin (or aluminum acetylsalicylate) is a platelet aggregation inhibitor. It is derived from aspirin.[1]
It is also known as "Palaprin Forte".[2]
References
- ↑ CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid". J. Pharm. Pharmacol. 15: 56-62. PMID 14024235.
- ↑ Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')". The British journal of clinical practice 22 (9): 392-4. PMID 4876729.
External links
WikiDoc Research Resources for Aloxiprin | |
|---|---|
| Articles on Aloxiprin | Most recent articles on Aloxiprin • Most cited articles on Aloxiprin • Review articles on Aloxiprin • Articles on Aloxiprin in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Aloxiprin | Powerpoint slides on Aloxiprin • Images of Aloxiprin • Photos of Aloxiprin • Podcasts & MP3s on Aloxiprin • Videos on Aloxiprin |
| Evidence Based Medicine Regarding Aloxiprin | Cochrane Collaboration on Aloxiprin • Bandolier on Aloxiprin • TRIP on Aloxiprin |
| Cost Effectiveness of Aloxiprin | Cost Effectiveness of Aloxiprin |
| Clinical Trials Involving Aloxiprin | Ongoing Trials on Aloxiprin at Clinical Trials.gov • Trial results on Aloxiprin • Clinical Trials on Aloxiprin at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Aloxiprin | US National Guidelines Clearinghouse on Aloxiprin • NICE Guidance on Aloxiprin • NHS PRODIGY Guidance • FDA on Aloxiprin • CDC on Aloxiprin |
| Textbook Information on Aloxiprin | Books and Textbook Information on Aloxiprin |
| Pharmacology Resources on Aloxiprin | Dosing of Aloxiprin • Drug interactions with Aloxiprin • Side effects of Aloxiprin • Allergic reactions to Aloxiprin • Overdose information on Aloxiprin • Carcinogenicity information on Aloxiprin • Aloxiprin in pregnancy • Pharmacokinetics of Aloxiprin • |
| Genetics, Pharmacogenomics, and Proteinomics of Aloxiprin | Genetics of Aloxiprin • Pharmacogenomics of Aloxiprin • Proteomics of Aloxiprin |
| Newstories on Aloxiprin | Aloxiprin in the news • Be alerted to news on Aloxiprin • News trends on Aloxiprin |
| Commentary on Aloxiprin | Blogs on Aloxiprin |
| Patient Resources on Aloxiprin | Patient resources on Aloxiprin • Discussion groups on Aloxiprin • Patient Handouts on Aloxiprin • Directions to Hospitals Treating Aloxiprin • Risk calculators and risk factors for Aloxiprin |
| Healthcare Provider Resources on Aloxiprin | Symptoms of Aloxiprin • Causes & Risk Factors for Aloxiprin • Diagnostic studies for Aloxiprin • Treatment of Aloxiprin |
| Continuing Medical Education (CME) Programs on Aloxiprin | CME Programs on Aloxiprin |
| International Resources on Aloxiprin | Aloxiprin en Espanol • Aloxiprin en Francais |
| Business Resources on Aloxiprin | Aloxiprin in the Marketplace • Patents on Aloxiprin |
| Informatics Resources on Aloxiprin | List of terms related to Aloxiprin |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
